CHOC is one of the state’s largest referral centers for the newborn screening program, which checks babies for many serious genetic disorders.
Leading-edge biomarker research aids in infantile spasms management
Much of infantile spasms research focuses on visual analysis of a patient’s EEG, whereas Dr. Daniel Shrey’s research uses a computation.
How COVID-19 survivors can support others through plasma donation
It’s possible that the plasma of recovered COVID-19 patients may have antibodies that could help in the treatment of others with COVID-19.
Virtual Mini-Hack to address problems amplified by COVID-19
Nurses and other participants from a range of disciplines will work in teams to devise answers, develop prototypes and pitch solutions.
Rapid genome testing for infants saves lives, costs
A recently completed pilot program at CHOC and other California clinical sites helped target a baby’s specific genetic disease in just days.
The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
